Back to Search
Start Over
Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer.
- Source :
-
Pain [Pain] 2023 Jul 01; Vol. 164 (7), pp. 1502-1511. Date of Electronic Publication: 2022 Dec 09. - Publication Year :
- 2023
-
Abstract
- Abstract: Paclitaxel-induced peripheral neuropathy (PIPN) is a barrier to effective cancer treatment and impacts quality of life among patients with cancer. We used a translational approach to assess the utility of neurofilament light chain (NFL) as a biomarker of PIPN in a human cell model and in patients with ovarian cancer. We measured NFL in medium from human induced pluripotent stem cell-derived sensory neurons (iPSC-SNs) exposed to paclitaxel. Serum NFL (sNFL) levels were quantified in 190 patients with ovarian cancer receiving paclitaxel/carboplatin chemotherapy at baseline and after each of the following 2 or 6 cycles. Adverse outcomes related to PIPN were retrospectively obtained, and Cox regression model was performed with different sNFL cut-offs after first cycle. The apparent elimination half-life of sNFL was estimated in patients who discontinued paclitaxel. Paclitaxel neurotoxicity in iPSC-SNs was accompanied by NFL release in a concentration-dependent manner ( P < 0.001, analysis of variance). Serum NFL levels increased substantially in patients during paclitaxel/carboplatin chemotherapy with considerable interindividual variability. Patients with sNFL >150 pg/mL after first cycle had increased risk to discontinue paclitaxel early (unadjusted HR: 2.47 [95% CI 1.16-5.22], adjusted HR: 2.25 [95% CI: 0.88-5.79]). Similar trends were shown for risk of severe PIPN and paclitaxel dose reduction because of PIPN. The median elimination half-life of sNFL was 43 days (IQR 27-82 days). Neurofilament light chain constitutes an objective biomarker of neurotoxicity in iPSC-SNs and in ovarian cancer patients with high sNFL predicting PIPN-related adverse outcomes. If prospectively validated, NFL can be used to study PIPN and may guide clinical decision making and personalize treatment with paclitaxel.<br /> (Copyright © 2023 International Association for the Study of Pain.)
- Subjects :
- Humans
Female
Paclitaxel adverse effects
Quality of Life
Retrospective Studies
Carboplatin adverse effects
Intermediate Filaments
Sensory Receptor Cells
Neurofilament Proteins
Biomarkers
Induced Pluripotent Stem Cells
Peripheral Nervous System Diseases chemically induced
Ovarian Neoplasms drug therapy
Ovarian Neoplasms chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1872-6623
- Volume :
- 164
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Pain
- Publication Type :
- Academic Journal
- Accession number :
- 36508173
- Full Text :
- https://doi.org/10.1097/j.pain.0000000000002840